Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 8-K Event Shareholder vote results
  4. SC 13G Stake Amended Statement of Ownership
  5. 424B5 Offering Prospectus
  6. 8-K Event Material agreement
  7. 424B5 Offering Prospectus
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. DEF 14A Proxy Proxy Statement
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. UPLOAD Other SEC-generated Letter
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. SC 13G Stake Amended Statement of Ownership
  16. UPLOAD Other SEC-generated Letter
  17. CT ORDER Other Confidential Order
  18. CT ORDER Other Confidential Order
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. 424B5 Offering Prospectus

Page 40 of 65 · 1,298 filings